PHVS Stock: Price, Earnings History and SEC Filings
Pharvaris N.V. (PHVS) last traded at $33.53, down 0.15% on the latest session and up 5.7% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.81 against an analyst estimate of $-0.74, a miss of 9.5%.
$33.53 -0.15%
1 month+5.71%
52-week high$43.25
52-week low$21.02
Volume1.48M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
PHVS earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 12, 2026 | $-0.81 | $-0.74 | -9.46% |
| Mar 2026 | May 12, 2026 | $-0.70 | $-0.76 | +7.89% |
| Sep 2025 | Nov 12, 2025 | $-0.70 | $-0.78 | +10.26% |
PHVS beat the analyst EPS estimate in 2 of its last 3 reported quarters. Source: Nasdaq.
Latest SEC filings for PHVS
SEC filing data is not available right now. You can search for PHVS on SEC EDGAR.
PHVS news
- Pharvaris to Present Clinical and Real-World Data at the ACAAI 2026 Annual Scientific MeetingOct 29, 2026 · finance.yahoo.com
- Bank of America backs Pharvaris on breakthrough for rare swelling diseaseOct 26, 2026 · thestreet.com
- Norwegian downgraded, Skydance upgraded: Wall Street's top analyst callsOct 23, 2026 · finance.yahoo.com
About Pharvaris N.V.
Pharvaris N.V. (PHVS) is a US-listed public company on Nasdaq.